Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Deirdre Cohen
NYU Langone Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California at Davis Cancer Center
Sacramento, California, United States
- University of Chicago
Chicago, Illinois, United States
- Cancer Care Center of Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Illinois Oncology Research Association Ccop
Peoria, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Michigan University Hospital
Ann Arbor, Michigan, United States
- Saint John'S Mercy Medical Center
St Louis, Missouri, United States
- Beth Israel Medical Center
New York, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- New York University Langone Medical Center
New York, New York, United States
- Saint Luke'S Roosevelt Hospital Center - Saint Luke'S Division
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Albert Einstein College of Medicine
The Bronx, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- New York Cancer Consortium
The Bronx, New York, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 30 Apr 2012
- Completion
- 31 Oct 2014
- Last update posted
- 25 Jan 2016
- Registered enrollment
- 124
- Registry id
- NCT00982592
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.